MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-22-2026
Quest Diagnostics Incorporated Cash Conversion Cycle 2011-2026 | DGX
Annual Cash Conversion Cycle Quest Diagnostics Incorporated
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 39.5 | 38.6 | 38 | 40.7 | 39.7 | 38.5 | 40.1 | 39.9 | 33.8 | 30.8 | 28.6 | 34.2 | 29.4 | 33.6 | 33.6 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 40.7 | 28.6 | 35.9 |
Quarterly Cash Conversion Cycle Quest Diagnostics Incorporated
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 57.6 | 55.7 | 56.1 | 57.3 | 59.4 | 60.7 | 60.6 | 60.9 | 59.6 | 59.1 | - | 28.6 | 31.1 | 50.4 | - | 55.9 | 59.5 | 48.7 | 46.2 | 62.7 | 92.6 | 67.7 | 50.4 | 58.5 | 58.5 | 50.1 | 50.2 | 56.3 | 55.4 | 45.8 | 45.2 | 52.7 | 52.6 | 44.3 | 45.4 | 51.3 | 50.8 | 40.2 | 44.5 | 50.3 | 49.2 | 43 | 45.2 | 53.2 | 53.3 | 44.3 | 44.3 | 51.1 | 50.4 | 43.1 | 44.6 | 51.3 | 49.8 | 41 | 44.8 | 50.7 | 50.8 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 92.6 | 28.6 | 51.7 |
Cash Conversion Cycle of other stocks in the Diagnostics research industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
154 | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
50.2 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
138 | - | - | $ 1.31 B | USA |
 |
DermTech
DMTK
|
66.7 | - | -11.32 % | $ 2.94 M | USA |
|
Akumin
AKU
|
36.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
-2.46 K | $ 4.1 | -4.43 % | $ 5.45 M | USA |
 |
Fulgent Genetics
FLGT
|
51.8 | $ 18.7 | 0.08 % | $ 576 M | USA |
 |
Castle Biosciences
CSTL
|
31.6 | $ 20.51 | -0.92 % | $ 595 M | USA |
 |
Aspira Women's Health
AWH
|
1.01 K | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
2.11 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
78.1 | - | -13.05 % | $ 7.29 M | USA |
 |
Interpace Biosciences
IDXG
|
62.9 | $ 1.6 | -3.03 % | $ 7.08 M | USA |
 |
Illumina
ILMN
|
147 | $ 161.5 | 0.33 % | $ 25 B | USA |
 |
Guardant Health
GH
|
79.6 | $ 129.51 | -1.61 % | $ 16.2 B | USA |
 |
CareDx, Inc
CDNA
|
51.5 | $ 22.75 | -0.96 % | $ 1.21 B | USA |
 |
Chembio Diagnostics
CEMI
|
111 | - | 0.22 % | $ 16.8 M | USA |
 |
ICON Public Limited Company
ICLR
|
52.5 | $ 146.68 | 0.34 % | $ 11.5 B |  Irlanda |
 |
HTG Molecular Diagnostics
HTGM
|
104 | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
184 | - | - | $ 399 M |  China |
 |
Mettler-Toledo International
MTD
|
66.4 | $ 1 146.92 | 1.58 % | $ 23.6 B |  Schweiz |
 |
Genetic Technologies Limited
GENE
|
11 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
142 | - | 0.12 % | $ 80.1 M | China |
 |
National Research Corporation
NRC
|
29.4 | $ 18.78 | -0.05 % | $ 420 M | USA |
 |
Natera
NTRA
|
48.3 | $ 211.42 | -0.31 % | $ 28.9 B | USA |
 |
Lantheus Holdings
LNTH
|
97.3 | $ 104.16 | -0.34 % | $ 7.03 B | USA |
 |
Pacific Biosciences of California
PACB
|
185 | $ 1.33 | 1.15 % | $ 399 M | USA |
 |
Charles River Laboratories International
CRL
|
65 | $ 190.12 | 1.39 % | $ 9.42 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.21 K | - | - | $ 10.7 B | USA |
 |
Medpace Holdings
MEDP
|
50.4 | $ 470.72 | 0.72 % | $ 13.6 B | USA |
 |
Exact Sciences Corporation
EXAS
|
42.5 | - | - | $ 19.8 B | USA |
 |
NeoGenomics
NEO
|
82.4 | $ 11.12 | -0.31 % | $ 1.42 B | USA |
 |
Myriad Genetics
MYGN
|
49.3 | $ 4.26 | -1.59 % | $ 394 M | USA |
 |
Personalis
PSNL
|
-1.89 | $ 9.7 | 1.15 % | $ 866 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
89 | $ 27.04 | 2.19 % | $ 25.6 B |  Niderland |
 |
Twist Bioscience Corporation
TWST
|
83.6 | $ 79.05 | 3.78 % | $ 4.73 B | USA |
 |
Senseonics Holdings
SENS
|
36.1 | $ 7.34 | 2.16 % | $ 306 M | USA |
 |
QIAGEN N.V.
QGEN
|
122 | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
-398 | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
172 | $ 2.05 | - | $ 4.71 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
40.3 | $ 265.64 | -0.2 % | $ 22.1 B | USA |
 |
Thermo Fisher Scientific
TMO
|
70 | $ 473.34 | 0.95 % | $ 178 B | USA |
 |
Trinity Biotech plc
TRIB
|
136 | $ 0.65 | - | $ 233 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K |  Israel |
 |
Neogen Corporation
NEOG
|
150 | $ 9.24 | 1.54 % | $ 2 B | USA |
 |
Invitae Corporation
NVTA
|
299 | - | - | $ 21.2 M | USA |